Essential Partners’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.79K Hold
78
– – ﹤0.01% 1786
2026
Q2
$2.45K Sell
78
-2
-3% -$84 ﹤0.01% 1893
2026
Q1
$4.42K Hold
80
– – ﹤0.01% 1637
2025
Q4
$2.99K Sell
80
-4
-5% -$162 ﹤0.01% 1646
2025
Q3
$3.4K Buy
84
+29
+53% +$958 ﹤0.01% 1582
2025
Q2
$1.41K Buy
+55
New +$1.2K ﹤0.01% 1419

Other funds holding PAHC

Essential Partners's PAHC Position: Q3 2026 in Review

Essential Partners held its Phibro Animal Health (PAHC) position steady in Q3 2026 at 78 shares worth $2.79K. The position accounts for ﹤0.01% of the portfolio, ranked #1786.

Essential Partners first reported a position in PAHC in Q2 2025 and has held it in 6 quarters since. The position peaked at $4.42K in Q1 2026. 10 funds tracked by Wall St. Rank hold PAHC as of Q3 2026.

  • Essential Partners held 78 shares of Phibro Animal Health worth $2.79K as of Q3 2026.
  • Essential Partners left its Phibro Animal Health share count unchanged in Q3 2026.
  • Phibro Animal Health made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #1786 holding.
  • Essential Partners first reported a position in Phibro Animal Health in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's Phibro Animal Health position peaked at $4.42K in Q1 2026.
  • 10 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.